文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

人偏肺病毒是成人重症社区获得性肺炎的病因:十年分子与流行病学分析

Human metapneumovirus as cause of severe community-acquired pneumonia in adults: insights from a ten-year molecular and epidemiological analysis.
PubMed 文献 · Ann Intensive Care · 2019-07-24
一句话结论人偏肺病毒可致成人重症社区获得性肺炎需入ICU,约四分之一合并肺炎链球菌感染,血浆降钙素原有助于抗菌药物管理。

该回顾性流行病学研究分析了十年间入住ICU的28例人偏肺病毒重症社区获得性肺炎成人患者(入院PSI评分≥3)。所有患者均有急性呼吸衰竭,60.7%入院时休克,50%接受机械通气,7例发生ARDS(其中3例年龄<60岁且无合并症),ICU死亡率为14.3%。25%的患者合并肺炎链球菌感染。合并细菌感染患者血浆降钙素原水平更高(18.2 vs 0.54;p<0.05),而C反应蛋白水平相似。人偏肺病毒可导致老年人或有合并症者以及健康年轻成人发生重症社区获得性肺炎,常需机械通气且医疗资源消耗高,血浆降钙素原有助于实施抗菌药物管理。

要点

  • 28例人偏肺病毒重症社区获得性肺炎成人患者中,60.7%入院时存在休克,50%接受机械通气,ICU死亡率为14.3%。
  • 25%的患者合并肺炎链球菌感染,合并细菌感染患者血浆降钙素原水平更高(18.2 vs 0.54;p<0.05),C反应蛋白水平相似。
  • 7例患者发生ARDS,其中3例年龄小于60岁且无合并症。
  • 92.8%的病例在一年上半年检出,基因分型以B组为主(60.7%)。
  • 幸存者ICU住院时间和总住院时间中位数分别为6.5天和14天。

适用人群与场景

  • 成人重症社区获得性肺炎患者,入院PSI评分≥3,入住ICU。

诊断标准与关键阈值

  • 入院PSI评分≥3。

红旗征与不能漏的情况

  • 急性呼吸衰竭:所有患者均出现。
  • 入院时休克:60.7%的患者。
  • ARDS:7例患者发生,其中3例年龄小于60岁且无合并症。

研究设计与关键结果

  • 研究类型:回顾性流行病学研究;样本量:28例成人人偏肺病毒重症社区获得性肺炎患者;人群:入住ICU、入院PSI评分≥3;主要结果:92.8%的病例在一年上半年检出,中位年龄62岁,60.7%为男性,基因分型B组占60.7%,所有患者有急性呼吸衰竭,中位APACHE II评分13,中位SOFA评分6.55,25%合并肺炎链球菌感染,60.7%入院时休克,50%接受机械通气,7例发生ARDS(其中3例年龄<60岁且无合并症),ICU死亡率为14.3%,幸存者ICU住院时间和总住院时间中位数分别为6.5天和14天;合并细菌感染患者血浆降钙素原水平更高(18.2 vs 0.54;p<0.05),C反应蛋白水平相似。

证据类型、等级与局限

  • 证据类型:回顾性流行病学研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,人偏肺病毒与需要入住ICU的重症社区获得性肺炎相关,可发生于老年人或有合并症者以及健康年轻成人;这些患者常需机械通气且医疗资源消耗高;约四分之一患者合并肺炎链球菌感染,血浆降钙素原有助于实施抗菌药物管理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Information on the clinical, epidemiological and molecular characterization of human metapneumovirus in critically ill adult patients with severe community-acquired pneumonia (CAP) and the role of biomarkers identifying bacterial coinfection is scarce.

METHODS: This is a retrospective epidemiological study of adult patients with hMPV severe CAP admitted to ICU during a ten-year period with admission PSI score ≥ 3.

RESULTS: The 92.8% of the 28 patients with severe CAP due to human metapneumovirus were detected during the first half of the year. Median age was 62 years and 60.7% were male. The genotyping of isolated human metapneumovirus showed group B predominance (60.7%). All patients had acute respiratory failure. Median APACHE II and SOFA score were 13 and 6.55, respectively. The 25% were coinfected with Streptococcus pneumoniae. 60.7% of the patients had shock at admission and 50% underwent mechanical ventilation. Seven patients developed ARDS, three of them younger than 60 years and without comorbidities. Mortality in ICU was 14.3%. Among survivors, ICU and hospital stay were 6.5 and 14 days, respectively. Plasma levels of procalcitonin were higher in patients with bacterial coinfection (18.2 vs 0.54; p < 0.05). The levels of C-reactive protein, however, were similar.

CONCLUSION: Human metapneumovirus was associated with severe CAP requiring ICU admission among elderly patients or patients with comorbidities, but also in healthy young subjects. These patients often underwent mechanical ventilation with elevated health resource consumption. While one out of four patients showed pneumococcal coinfection, plasma procalcitonin helped to implement antimicrobial stewardship.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Vidaur L, Totorika I, Montes M, et al. Human metapneumovirus as cause of severe community-acquired pneumonia in adults: insights from a ten-year molecular and epidemiological analysis. Ann Intensive Care. 2019. PMID: 31342206. doi:10.1186/s13613-019-0559-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。